# Effects of Octanoic Acid for Treatment of Essential Voice Tremor

> **NCT01864525** · PHASE1,PHASE2 · COMPLETED · sponsor: **Syracuse University** · enrollment: 17 (actual)

## Conditions studied

- Essential Voice Tremor
- Vocal Tremor
- Voice Tremor
- Essential Tremor of Voice

## Interventions

- **DRUG:** Octanoic acid
- **DRUG:** Inactive capsule

## Key facts

- **NCT ID:** NCT01864525
- **Lead sponsor:** Syracuse University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2016-12-22
- **Final completion:** 2017-03-31
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2018-08-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01864525

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01864525, "Effects of Octanoic Acid for Treatment of Essential Voice Tremor". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01864525. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*